Sograzepide, CAS [[155488-25-8]]

Produktübersicht

• Artikelname: Sograzepide, CAS [[155488-25-8]]
• Artikelnummer: BYT-ORB1706618
• Hersteller Artikelnummer: orb1706618
• Alternativnummer: BYT-ORB1706618-1, BYT-ORB1706618-1, BYT-ORB1706618-5
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Sograzepide, YM 220, YF476, YF-476, YF 476, YM220, YM-220, Netazepide, Gastrin, Gastrin/CCK-A, Gastrin/CCK-B

Produktbeschreibung

Sograzepide (Netazepide) is a potent, selective, and orally bioavailable gastrin/CCK-B receptor antagonist. It suppresses gastrin-mediated signaling and pappalysin 2 expression, demonstrating the ability to induce regression of type 1 gastric neuroendocrine tumors (gNETs) in clinical research. This small molecule is a valuable tool for investigating gastrin biology and gNET pathogenesis in both in vitro and in vivo models.

Produkteigenschaften

• Molekulargewicht: 498.58
• CAS Nummer: [155488-25-8]
• Formel: C28H30N6O3
• Target-Kategorie: Cholecystokinin Receptor,Others

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.62 mM),DMSO:80 mg/mL (160.46 mM)